Ocular therapeutix™ reports inducement grant under nasdaq listing rule 5635(c)(4)

Bedford, mass., dec. 13, 2024 (globe newswire) -- ocular therapeutix, inc. (nasdaq:ocul, “ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions, today announced that it has agreed to grant inducement awards to one newly hired employee. the awards were made as inducements material to the individual's acceptance of employment with ocular under ocular's 2019 inducement stock incentive plan in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking